Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signalingYuze Zhang, Dajun Chai|Cardiovascular Diabetology|2021Cited by 98
Dapagliflozin: a Sodium-glucose Cotransporter 2 Inhibitor, Attenuates Angiotensin II-induced Cardiac Fibrotic Remodeling by Regulating TGFβ1/ Smad SignalingYuze Zhang, Dajun Chai|Research Square|2021Cited by 0